18 Apr 2026
Pyridine-2,6-dicarboxylic acid derivatives of potential antileishmanial activity: synthesis, biological evaluation, and in-silico studiesPublisher siteBioorganic & Medicinal Chemistry Letters, Research on Leishmaniasis Studies
UniversitiesAdnan A. Bekhit
Active, last published 2026
Adnan A.
Bekhit
Scholar“Research profile drawn from open scholarly records.”
University of Bahrain
Claim Your Profile0
H-index
0
Citations
Adnan has not officially claimed their profile. If you are Adnan, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Adnan A. Bekhit will appear here once their profile is updated.
02 · Reach
Publication output and reach
Adnan's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchUniversity of BahrainDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
3 works30 Mar 2026
Thiazole‐Semicarbazone Hybrids as Dual‐Stage Inhibitors of <i>Leishmania major</i> Growth: Design, Synthesis, and Mechanistic InsightsPublisher siteDrug Development Research, Research on Leishmaniasis Studies
1 Mar 2026Open access
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major GrowthPublisher siteDrug Design Development and Therapy, Research on Leishmaniasis Studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Adnan?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you